|
|
David Y. Hui
J Clin Invest. 2003;
111(3):317
doi:10.1172/JCI17746
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(5)
| Title and authors |
Publication |
Year |
Molecular Mechanisms of HIV Protease Inhibitor-Induced Endothelial Dysfunction
Xinwen Wang, Hong Chai, Qizhi Yao, Changyi Chen
|
JAIDS Journal of Acquired Immune Deficiency Syndromes
|
2007 |
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART)
François-Jérôme Authier, Patrick Chariot, Romain K. Gherardi
|
Muscle Nerve
|
2005 |
Thrombotic Complications in Patients Infected with HIV in the Era of Highly Active Antiretroviral Therapy: A Case Series
M. C. Jacobson, B. J. Dezube, D. M. Aboulafia
|
CLIN INFECT DIS
|
2004 |
Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy
J. Fredriksen, T. Ueland, E. Dyroy, B. Halvorsen, K. Melby, L. Melbye, B. S. Skalhegg, P. Bohov, J. Skorve, R. K. Berge, P. Aukrust, S. S. Froland
|
European Journal of Clinical Investigation
|
2004 |
Current awareness: Pharmacoepidemiology and drug safety
|
Pharmacoepidem. Drug Safe.
|
2003 |
|
